Description
Lifespan analysis of dystrophin-mutant C. elegans with and without sulfur amino acid supplementation demonstrates that the treatment does not adversely affect longevity and may provide modest survival benefits.
Figure 5
ChartSource Paper
Sulfur amino acid supplementation displays therapeutic potential in a C. elegans model of Duchenne muscular dystrophy.Cite This Figure
![Figure 5: Lifespan analysis of dystrophin-mutant C. elegans with and without sulfur amino acid supplementation demonstrates that the treatment does not adversely affect longevity and may provide modest survival benefits.]() > Source: Rebecca A Ellwood et al. "Sulfur amino acid supplementation displays therapeutic potential in a C. elegans." *Communications biology*, 2022. PMID: [36385509](https://pubmed.ncbi.nlm.nih.gov/36385509/)
<figure> <img src="" alt="Lifespan analysis of dystrophin-mutant C. elegans with and without sulfur amino acid supplementation demonstrates that the treatment does not adversely affect longevity and may provide modest survival benefits." /> <figcaption>Figure 5. Lifespan analysis of dystrophin-mutant C. elegans with and without sulfur amino acid supplementation demonstrates that the treatment does not adversely affect longevity and may provide modest survival benefits.<br> Source: Rebecca A Ellwood et al. "Sulfur amino acid supplementation displays therapeutic potential in a C. elegans." <em>Communications biology</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36385509/">36385509</a></figcaption> </figure>